MRI-guided radiation for prostate cancer patients
Part of Cancer, Kidney & urinary clinical trials.
This study tests radiation treatment planned and guided using MRI scans (“image-guided radiotherapy”) for men with prostate cancer who are aiming for a cure. If you qualify, you may receive radiation with more precise targeting using MRI to help deliver treatment accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have prostate cancer confirmed by biopsy (histology)
- Your prostate cancer is being treated with the goal of cure
- You can do normal activities or are only mildly limited (ECOG 0–2)
- You are able to give informed consent
- You can safely have MRI scans (no MRI safety problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using MRI scans to guide radiation can allow lower doses to the healthy parts of the prostate, potentially reducing side effects. It is for men with intermediate- or high-risk prostate cancer that can be seen on MRI and has not spread.
This trial tests a newer way to plan and deliver radiation for prostate cancer using real-time MRI guidance. It may help by aiming high-dose treatment precisely while treating nearby disease and (in some cases) limited metastatic spots.
This trial tests a precise, MRI-guided radiation treatment given over 7 days for people with prostate cancer in specific risk categories. It may help shrink or control the cancer while carefully targeting the tumor.
This trial tests a precise, short course of radiation therapy guided by MRI for men with low or favorable intermediate-risk prostate cancer. It aims to offer effective treatment with fewer sessions and fewer side effects.
This study tests whether adding a stronger, focused radiation “boost” to a visible prostate spot—using real-time MRI guidance—can improve treatment for locally advanced prostate cancer. It may help better control the tumor while still delivering standard radiation to the rest of the prostate area.
This study tests a higher dose of radiation for prostate cancer using an MRI-guided machine (MR-Linac). It aims to see if a more targeted dose can be safely given to the tumor while protecting healthy tissue.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.